Regencell Bioscience Holdings Limited (RGC) Net Income by Year
Regencell Bioscience Holdings Limited reported a net loss of $3.6M in fiscal year 2025. This represents an increase of 16.7% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Regencell Bioscience Holdings Limited has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RGC Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RGC Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Regencell Bioscience Holdings Limited financials
Frequently Asked Questions
What was Regencell Bioscience Holdings Limited's net income in fiscal year 2025?
Regencell Bioscience Holdings Limited reported a net loss of $3.6M in fiscal year 2025.
How fast is Regencell Bioscience Holdings Limited's net income growing?
Regencell Bioscience Holdings Limited (RGC) net income rose by 16.7% year over year, from -$4.3M to -$3.6M in fiscal year 2025.
How has Regencell Bioscience Holdings Limited's net income changed over the years?
Across the 7 fiscal years this page covers, Regencell Bioscience Holdings Limited (RGC) net income went from -$391K in fiscal year 2019 to -$3.6M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Regencell Bioscience Holdings Limited (RGC) reported on that line in every period on record.